Table 1 Baseline characteristics
Patient characteristics | Overall (N = 225) | No CVC malfunction (N = 163) | CVC malfunction (N = 62) |
|---|---|---|---|
Treatment | |||
Rt-PA Group | 110 (48.9%) | 88 (54.0%) | 22 (35.5%) |
Heparin only Group | 115 (51.1%) | 75 (46.0%) | 40 (64.5%) |
Age -yr, mean ± SD | 63.2 (15.9) | 62.4 (16.6) | 65.4 (14.0) |
Female sex – no. (%) | 88 (39.1%) | 58 (35.6%) | 30 (48.4%) |
Duration of dialysis –yr, median (IQR) | 1.0 (0.0 - 6.0) | 1.0 (0.0 - 6.0) | 0.0 (0.0 - 1.0) |
Central venous catheter Indication - no. (%): | |||
Starting dialysis without peripheral access | 118 (52.4%) | 84 (51.5%) | 34 (54.8%) |
Failure of/awaiting peripheral access | 48 (21.3%) | 32 (19.6%) | 16 (25.8%) |
Catheter related infection | 14 (6.22%) | 11 (6.75%) | 3 (4.84%) |
First dialysis catheter ever - no. (%) | 137 (60.9%) | 99 (60.7%) | 38 (61.3%) |
Cause of end-stage renal disease: | |||
Diabetic nephropathy | 71 (31.6%) | 48 (29.4%) | 23 (37.1%) |
Glomerulonephritis | 17 (7.56%) | 12 (7.36%) | 5 (8.06%) |
Hypertension or vascular disease | 42 (18.7%) | 35 (21.5%) | 7 (11.3%) |
Coexisting or prior illness - no. (%): | |||
Diabetes mellitus | 124 (55.1%) | 86 (52.8%) | 38 (61.3%) |
Hypertension | 206 (91.6%) | 150 (92.0%) | 56 (90.3%) |
Ischemic heart disease | 47 (20.9%) | 34 (20.9%) | 13 (21.0%) |
Hemoglobin - g/liter, mean ± SD | 106 (15.7) | 106 (15.8) | 106 (15.4) |
Albumin – g/liter, mean ± SD | 32.1 (6.5) | 32.1 (6.7) | 32.0 (5.9) |
Platelet count - x10-9/litre, median (IQR) | 230 (185–293) | 233 (185–298) | 220 (183–283) |